… Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) diagnosed in core
… for developing invasive ductal or lobular carcinoma in either breast. Currently, there are no …

… Two thousand three hundred thirty-seven breast core needle biopsies were performed at
our institution as a result of an indeterminate or suspicious clinical, mammographic, or …

… risk of ADH or DCIS at the site of lobular neoplasia at core biopsy. Even when microcalcifications
are retrieved at core biopsy, an adjacent breast cancer can be missed. At detailed …

… breast lesions that yield classic lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia
(ALH) (known together as classic lobular … risk lesion at percutaneous core-needle biopsy (…

… Is surgical excision necessary for the management of atypical lobular hyperplasia and
lobular carcinoma in situ diagnosed on core needle biopsy? A report of 38 cases and review of …

… %) were upgraded to invasive lobular carcinoma in surgical excision (4 … core biopsies in
the past may represent LCIS variants. These show a 25% upgrade to invasive lobular carcinoma …

… We conclude that a finding of LN on breast core biopsy in a patient with a BIRADS 4 image …
on core biopsy is upstaged to ductal carcinoma in situ (DCIS) or invasive carcinoma on follow-…

… as a method to limit the number of patients requiring surgical excision when atypical
lobular hyperplasia (ALH) or lobular carcinoma in situ (LCIS) is diagnosed at core biopsy. …

… breast lesions may be of use22 with needle core having a reported 100% sensitivity and
specificity for lobular carcinomas for a … It must be remembered, however, that even large lobular …

… Therefore, we advocate further surgical excision after core biopsy for the pleomorphic
type of lobular carcinoma in situ in particular. Confirmation of our observations by other …